---
figid: PMC3728269__ijn-8-2677Fig1
figtitle: 'Signaling pathways in melanoma.Notes: Oncoprotein Ras activates both the
  MAPK and PI3K/Akt survival pathways'
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Human papillomavirus
pmcid: PMC3728269
filename: ijn-8-2677Fig1.jpg
figlink: /pmc/articles/PMC3728269/figure/f1-ijn-8-2677/
number: F1
caption: 'Signaling pathways in melanoma.Notes: Oncoprotein Ras activates both the
  MAPK and PI3K/Akt survival pathways. Ras can stimulate BRAF activity, which in turn,
  activates MEK and ERK1/2. Ras also activates PI3K, which catalyzes PIP2 into PIP3.
  PIP3 increases Akt activity via PDK. Both Akt and ERK1/2 act on the mitochondrial
  apoptosis signaling pathway and mTORC1. Akt also targets VEGF and NF-kB. ERK1/2
  can also activate STAT3 and other transcriptional factors, such as MNK1/2, MSK1/2,
  ELK, ETS, RSK, PPAR, ELK1, and ETS.Abbreviations: Akt, protein kinase B; Bcl-2,
  B cell lymphoma protein 2; Bcl-XL, B cell lymphoma protein extra large; BRAF, v-Raf
  murine sarcoma viral oncogene homolog B1; ELK1, member of the E-twenty-six transcriptional
  family; ERK, extracellular signal-regulated kinase; ETS, E-twenty-six (transcriptional
  family); MAPK, mitogen-activated protein kinase; MEK, MAPK kinase; MNK1, 2, MAPK-interacting
  kinases 1, 2; MSK1, 2, stress-activated kinases 1, 2; mTORC1, mammalian target of
  rapamycin complex 1; NF-kB, nuclear factor-kappaB; PI3K, phosphoinositide 3-kinase;
  PIP2, phosphatidylinositol-4,5-bisphosphate; PIP3, phosphatidylinositol-3,4,5-trisphosphate;
  PDK, putative 3-phosphoinositide-dependent kinase; PPAR, peroxisome-proliferator-activated
  receptor; Ras, rat sarcoma protein (subfamily of small GTPases); RSK, 90-kDa ribosomal
  S6 protein kinase; STAT3, signal transducer and activator of transcription 3; VEGF,
  vascular endothelial growth factor.'
papertitle: Applications of nanotechnology for melanoma treatment, diagnosis, and
  theranostics.
reftext: Jiezhong Chen, et al. Int J Nanomedicine. 2013;8:2677-2688.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9468298
figid_alias: PMC3728269__F1
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
redirect_from: /figures/PMC3728269__F1
ndex: 096cd582-def6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3728269__ijn-8-2677Fig1.html
  '@type': Dataset
  description: 'Signaling pathways in melanoma.Notes: Oncoprotein Ras activates both
    the MAPK and PI3K/Akt survival pathways. Ras can stimulate BRAF activity, which
    in turn, activates MEK and ERK1/2. Ras also activates PI3K, which catalyzes PIP2
    into PIP3. PIP3 increases Akt activity via PDK. Both Akt and ERK1/2 act on the
    mitochondrial apoptosis signaling pathway and mTORC1. Akt also targets VEGF and
    NF-kB. ERK1/2 can also activate STAT3 and other transcriptional factors, such
    as MNK1/2, MSK1/2, ELK, ETS, RSK, PPAR, ELK1, and ETS.Abbreviations: Akt, protein
    kinase B; Bcl-2, B cell lymphoma protein 2; Bcl-XL, B cell lymphoma protein extra
    large; BRAF, v-Raf murine sarcoma viral oncogene homolog B1; ELK1, member of the
    E-twenty-six transcriptional family; ERK, extracellular signal-regulated kinase;
    ETS, E-twenty-six (transcriptional family); MAPK, mitogen-activated protein kinase;
    MEK, MAPK kinase; MNK1, 2, MAPK-interacting kinases 1, 2; MSK1, 2, stress-activated
    kinases 1, 2; mTORC1, mammalian target of rapamycin complex 1; NF-kB, nuclear
    factor-kappaB; PI3K, phosphoinositide 3-kinase; PIP2, phosphatidylinositol-4,5-bisphosphate;
    PIP3, phosphatidylinositol-3,4,5-trisphosphate; PDK, putative 3-phosphoinositide-dependent
    kinase; PPAR, peroxisome-proliferator-activated receptor; Ras, rat sarcoma protein
    (subfamily of small GTPases); RSK, 90-kDa ribosomal S6 protein kinase; STAT3,
    signal transducer and activator of transcription 3; VEGF, vascular endothelial
    growth factor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Hras
  - Kras
  - Rem1
  - pk
  - Braf
  - Braf-rs1
  - Mdk
  - Akt1
  - Mapk3
  - Mapk1
  - Vegfa
  - Bcl2
  - Stat3
  - Mknk2
  - Mknk1
  - Ppara
  - Bcl2l1
  - Rps6ka4
  - Rps6ka5
  - Elk1
  - Kcnh8
  - Rps6ka1
  - KRAS
  - HRAS
  - NRAS
  - BRAF
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - PDK1
  - PDK2
  - PDK3
  - PDK4
  - AKT1
  - AKT2
  - AKT3
  - MAPK3
  - MAPK1
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - BCL2
  - STAT3
  - MTOR
  - RPTOR
  - MKNK2
  - MKNK1
  - PPARA
  - PPARD
  - PPARG
  - RPS6KA4
  - RPS6KA5
  - ELK1
  - KCNH4
  - KCNH8
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPS6KA6
  - RPS6KB1
  - RPS6KB2
  - ETS1
  - ETS2
  - Cancer
---
